Clinical profile of patients with type 2 diabetes after COVID-19 vaccination: A prospective study

Maria Cristina Carrondo; Joaquim Jorge Moita

doi:10.1016/j.obmed.2022.100458

Clinical profile of patients with type 2 diabetes after COVID-19 vaccination: A prospective study

Obes Med. 2022 Oct:35:100458. doi: 10.1016/j.obmed.2022.100458. Epub 2022 Oct 14.

Authors

Maria Cristina Carrondo¹, Joaquim Jorge Moita²

Affiliations

¹ Polytechnic Institute of Coimbra College of Health Technology of Coimbra, Department Medical, Social, and Human Sciences, Portugal.
² Hospital Center and University of Coimbra, Coimbra, Portugal.

Abstract

The purpose of this study was to characterize the clinical profile of patients with type 2 diabetes after COVID-19 vaccination. This prospective study has involved 100 adult diabetic patients followed in the primary health care. SARS-CoV-2 infection after COVID-19 vaccination was the outcome indicator.

Keywords: BMI, body mass index; Hypercholesterolemia; Obesity; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; Severe acute respiratory syndrome coronavirus 2; T2D, type 2 diabetes; Type 2 diabetes; Vaccination.